Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Following a setback, Pfizer gets a win in Phase III cancer drug study
Following a setback, Pfizer gets a win in Phase III cancer drug study
Following a setback, Pfizer gets a win in Phase III cancer drug study
Submitted by
admin
on April 21, 2015 - 9:51am
Source:
Fierce Biotech
News Tags:
Pfizer
clinical trials
CD22-positive non-Hodgkin's lymphoma
inotuzumab ozogamicin
Headline:
Following a setback, Pfizer gets a win in Phase III cancer drug study
Do Not Allow Advertisers to Use My Personal information
